HK1204476A1 - 治療癌症的化合物和方法 - Google Patents

治療癌症的化合物和方法

Info

Publication number
HK1204476A1
HK1204476A1 HK15104992.3A HK15104992A HK1204476A1 HK 1204476 A1 HK1204476 A1 HK 1204476A1 HK 15104992 A HK15104992 A HK 15104992A HK 1204476 A1 HK1204476 A1 HK 1204476A1
Authority
HK
Hong Kong
Prior art keywords
cancer
compounds
treatment
methods
Prior art date
Application number
HK15104992.3A
Other languages
English (en)
Inventor
‧辛加羅
‧達茲卡爾
‧弗雷瑞克
‧坎塔爾吉安
‧索特羅-勒瑪
‧福斯托弗塞克
‧高
Original Assignee
Texas A & M Univ Sys
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A & M Univ Sys, Univ Texas filed Critical Texas A & M Univ Sys
Publication of HK1204476A1 publication Critical patent/HK1204476A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/72—Aliphatic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/74—Aromatic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/80—Heterocyclic compounds
    • C07F9/82—Arsenic compounds containing one or more pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK15104992.3A 2004-07-16 2015-05-26 治療癌症的化合物和方法 HK1204476A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58859604P 2004-07-16 2004-07-16

Publications (1)

Publication Number Publication Date
HK1204476A1 true HK1204476A1 (zh) 2015-11-20

Family

ID=35414967

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104992.3A HK1204476A1 (zh) 2004-07-16 2015-05-26 治療癌症的化合物和方法

Country Status (11)

Country Link
US (2) US7405314B2 (zh)
EP (1) EP1771459A2 (zh)
JP (3) JP5618461B2 (zh)
KR (5) KR101252866B1 (zh)
CN (3) CN105777811A (zh)
AU (1) AU2005274926B2 (zh)
CA (2) CA2574032C (zh)
HK (1) HK1204476A1 (zh)
IL (2) IL180729A (zh)
TW (3) TW201350113A (zh)
WO (1) WO2006020048A2 (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2462932A1 (en) 2002-01-07 2012-06-13 Board Of Regents, The University Of Texas System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
US7628810B2 (en) 2003-05-28 2009-12-08 Acufocus, Inc. Mask configured to maintain nutrient transport without producing visible diffraction patterns
TW201350113A (zh) * 2004-07-16 2013-12-16 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
EP1919564B1 (en) * 2005-07-29 2014-11-26 Ziopharm Oncology, Inc. Compounds and methods for the treatment of cancer
US8222440B2 (en) * 2006-01-13 2012-07-17 The Texas A&M University System Compounds and methods for the treatment of cancer
TW200829261A (en) * 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals
KR20100100835A (ko) 2007-11-02 2010-09-15 지오팜 온콜로지 인코포레이티드 유기 비소제와의 병용 요법
KR20100097679A (ko) * 2007-12-12 2010-09-03 지오팜 온콜로지 인코포레이티드 암 치료 화합물 및 방법
CN102149432A (zh) 2008-08-20 2011-08-10 Zio医药肿瘤学公司 用于治疗癌症的有机砷化合物和方法
CN102060722B (zh) * 2009-05-01 2014-06-11 常州高新技术产业开发区三维工业技术研究所有限公司 一种含砷化合物及其制备方法和用途
US10004593B2 (en) 2009-08-13 2018-06-26 Acufocus, Inc. Intraocular lens with elastic mask
ES2970433T3 (es) 2009-08-13 2024-05-28 Acufocus Inc Método de fabricación de implantes intraoculares con máscara y lentes
US8809562B2 (en) 2011-06-06 2014-08-19 Chevron Phillips Chemical Company Lp Use of metallocene compounds for cancer treatment
US9545303B2 (en) 2011-12-02 2017-01-17 Acufocus, Inc. Ocular mask having selective spectral transmission
US9427922B2 (en) 2013-03-14 2016-08-30 Acufocus, Inc. Process for manufacturing an intraocular lens with an embedded mask
US20160304546A1 (en) * 2013-12-05 2016-10-20 Solasia Pharma K.K. Compounds and methods for the treatment of cancer
GB201418491D0 (en) * 2014-10-17 2014-12-03 Monfort University De Compounds
US9943403B2 (en) 2014-11-19 2018-04-17 Acufocus, Inc. Fracturable mask for treating presbyopia
ES2972581T3 (es) 2015-10-05 2024-06-13 Acufocus Inc Métodos de moldeo de lentes intraoculares
US11464625B2 (en) 2015-11-24 2022-10-11 Acufocus, Inc. Toric small aperture intraocular lens with extended depth of focus
CN105330701B (zh) * 2015-11-27 2017-05-31 昆明医科大学 一种含砷化合物及其制备方法和应用
WO2019217471A1 (en) 2018-05-09 2019-11-14 Acufocus, Inc. Intraocular implant with removable optic

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1621077B1 (en) 1997-10-15 2008-09-24 Polarx Biopharmaceuticals, Inc. Phamaceutical compositions comprising arsenic trioxide for the treatment of a tumor of the central nervous system
ID25622A (id) 1997-11-10 2000-10-19 Sloan Kettering Inst Cancer Proses untuk memproduksi formulasi arsenat trioksida dan metoda untuk mengobati kanker dengan menggunakan arsenat trioksida atau melarsoprol
CN1233476A (zh) 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
EP1002537A1 (en) 1998-10-30 2000-05-24 Assistance Publique, Hopitaux De Paris Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma
US6191123B1 (en) 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds
JP5242877B2 (ja) 2000-04-26 2013-07-24 オレゴン ヘルス アンド サイエンス ユニバーシティー チオールをベースとする化学保護剤の投与
EP2462932A1 (en) * 2002-01-07 2012-06-13 Board Of Regents, The University Of Texas System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
TW201350113A (zh) * 2004-07-16 2013-12-16 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物

Also Published As

Publication number Publication date
US20060128682A1 (en) 2006-06-15
CA2777473C (en) 2013-08-27
KR101252866B1 (ko) 2013-04-10
CN105777811A (zh) 2016-07-20
KR20130001323A (ko) 2013-01-03
WO2006020048A3 (en) 2006-08-24
WO2006020048A2 (en) 2006-02-23
CA2574032C (en) 2015-02-24
JP2012051919A (ja) 2012-03-15
WO2006020048B1 (en) 2006-10-19
EP1771459A2 (en) 2007-04-11
TWI411431B (zh) 2013-10-11
JP5745660B2 (ja) 2015-07-08
CN101076533A (zh) 2007-11-21
KR20130095857A (ko) 2013-08-28
CA2574032A1 (en) 2006-02-23
IL180729A0 (en) 2007-06-03
KR20070046120A (ko) 2007-05-02
KR20140136525A (ko) 2014-11-28
TW201440760A (zh) 2014-11-01
US7405314B2 (en) 2008-07-29
IL215896A0 (en) 2011-12-29
TW201350113A (zh) 2013-12-16
JP2014122233A (ja) 2014-07-03
AU2005274926A1 (en) 2006-02-23
CN104163833A (zh) 2014-11-26
JP2008506710A (ja) 2008-03-06
TW200616615A (en) 2006-06-01
CN101076533B (zh) 2013-11-06
US20080090793A1 (en) 2008-04-17
IL180729A (en) 2012-03-29
JP5618461B2 (ja) 2014-11-05
AU2005274926B2 (en) 2011-04-28
KR20140013110A (ko) 2014-02-04
CA2777473A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
HK1204476A1 (zh) 治療癌症的化合物和方法
EP1811844A4 (en) METHOD FOR THE DIAGNOSIS AND TREATMENT OF CANCER
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
EP1732650A4 (en) COMPOSITION AND METHOD FOR CANCER TREATMENT
EP1663259A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
EP1667680A4 (en) COMBINED METHODS OF TREATING CANCER
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
IL188746A0 (en) Treatment of cancer
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
EP1838714A4 (en) METHODS OF TREATING PAIN
EP1812596A4 (en) TREATMENT OF CANCER AND COMPOSITIONS
HK1164767A1 (zh) 治療癌症的化合物及方法
IL179129A0 (en) Kit for treatment of cancer
EP1796691A4 (en) INORGANIC SELENIUM FOR THE TREATMENT OF CANCER
EP1904088A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER
IL226363A0 (en) Compounds and methods for treating cancer
GB0520067D0 (en) Treatment of cancer
GB0426196D0 (en) Methods of treatment
GB0329416D0 (en) Treatment of cancer
GB0410379D0 (en) Treatment of cancer
IL180709A0 (en) Treatment of tumours
GB0423273D0 (en) Treatment of cancer
GB0420845D0 (en) Treatment of cancer
GB0422225D0 (en) Treatment of cancer
IL180460A0 (en) Treatment of cancer